Placenta
Volume 29, Issue 11 , Pages 950-955 , November 2008

Vasoactivity to and Endogenous Release of Vascular Endothelial Growth Factor in the in vitro Perfused Human Placental Lobule from Pregnancies Complicated by Preeclampsia

,Accepted 25 August 2008.

References 

  1. Thornburg KL. Fetal response to intrauterine stress. Ceba Found Symp. 1991;156:17–29
  2. Severi FM, Rizzo G, Bocchi C, D'Antona D, Verzuri MS, Arduini D. Intrauterine growth retardation and fetal cardiac function. Fetal Diagn Ther. 2000;15:8–19
  3. Poston L. The control of blood flow to the placenta. Exp Physiol. 1997;82:377–387
  4. Brownbill P, Bell NJ, Woods RJ, Lowry PJ, Page NM, Sibley CP. Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J Clin Endocrinol Metab. 2003;88:2164–2170
  5. Benoit C, Zavecz J, Wang Y. Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas. Placenta. 2007;28:498–504
  6. Read MA, Boura AL, Walters WA. Effects of variation in oxygen tension on responses of the human fetoplacental vasculature to vasoactive agents in vitro. Placenta. 1995;16:667–678
  7. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol. 1985;92:23–30
  8. Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod. 1997;12:167–172
  9. Holcberg G, Huleihel M, Sapir O, Katz M, Tsadkin M, Furman B, et al. Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol. 2001;94:69–72
  10. Okamura K, Murotsuki J, Watanabe T, Tanigawara S, Uehara M, Yano M, et al. Relation between fetal blood gas levels and the outcome of babies in severe preeclampsia. Tohoku J Exp Med. 1992;167:279–285
  11. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol. 1995;173:714–718
  12. Trudinger B, Wang J, Athayde N, Beutler L, Wang X. Association of umbilical placental vascular disease with fetal acute inflammatory cytokine responses. J Soc Gynecol Investig. 2002;9:152–157
  13. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertens Pregnancy. 2003;22:109–127
  14. Kofinas AD, Penry M, Nelson LH, Meis PJ, Swain M. Uterine and umbilical artery flow velocity waveform analysis in pregnancies complicated by chronic hypertension or preeclampsia. South Med J. 1990;83:150–155
  15. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors. 1995;12:235–243
  16. Lash GE, Taylor CM, Trew AJ, Cooper S, Anthony FW, Wheeler T, et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors. 2002;20:189–196
  17. Brownbill P, McKeeman GC, Brockelsby JC, Crocker IP, Sibley CP. Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology. 2007;148:4734–4744
  18. Szukiewicz D, Szewczyk G, Watroba M, Kurowska E, Maslinski S. Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol Obstet Invest. 2005;59:102–107
  19. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 1995;86:815–821
  20. Brockelsby JC. Increased circulating levels of vascular endothelial growth factor in preeclamsia. Hypertens Pregnancy. 1998;17:283–290
  21. Lyall F, Greer IA, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 1997;104:223–228
  22. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658
  23. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683
  24. Lee ES, Oh MJ, Jung JW, Lim JE, Seol HJ, Lee KJ, et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci. 2007;22:94–98
  25. Lyall F, Young A, Boswell F, Kingdom JC, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta. 1997;18:269–276
  26. Myatt L. Role of placenta in preeclampsia. Endocrine. 2002;19:103–111
  27. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604–4613
  28. Brownbill P, Sibley CP. Regulation of transplacental water transfer: the role of fetoplacental venous tone. Placenta. 2006;27:560–567
  29. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol. 1972;114:822–828
  30. Wilcox MA, Johnson IR, Maynard PV, Smith SJ, Chilvers CE. The individualised birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol. 1993;100:342–347
  31. Illsley NP, Fox H, Van der Veen F, Chawner L, Penfold P. Human placental ultrastructure after in vitro dual perfusion. Placenta. 1985;6:23–32
  32. Dancis J. The transfer of nutrients across the perfused human placenta. Adv Nutr Res. 1990;8:1–10
  33. Walters WA, Boura AL. Regulation of fetal vascular tone in the human placenta. Reprod Fertil Dev. 1991;3:475–481
  34. Schneider H. Techniques: in vitro perfusion of human placenta. In:  Sastry BVR editors. Placental toxicology. London: CRC; 1995;p. 1–25
  35. Schneider H. Placental oxygen consumption. Part II: In vitro studies – a review. Placenta. 2000;21:S38–S44
  36. Achen MG, Gad JM, Stacker SA, Wilks AF. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors. 1997;15:69–80
  37. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen – a review. Placenta. 2000;21(Suppl A):S16–S24
  38. Green CJ, Lichtlen P, Huynh NT, Yanovsky M, Laderoute KR, Schaffner W, et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res. 2001;61:2696–2703
  39. Knock GA, Sullivan MH, McCarthy A, Elder MG, Polak JM, Wharton J. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther. 1994;271:1007–1015
  40. Ong SS, Crocker IP, Warren AY, Baker PN. Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with pre-eclampsia. Hypertens Pregnancy. 2002;21:175–183

PII: S0143-4004(08)00290-7

doi: 10.1016/j.placenta.2008.08.020

Placenta
Volume 29, Issue 11 , Pages 950-955 , November 2008

Article Tools

* Image Usage & Resolution